Corvus Pharmaceuticals, Inc.   Report issue

For profit Phase 1 Phase 3
Founded: Burlingame CA United States (2014)

Organization Overview

First Clinical Trial
2016
NCT02655822
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Corvus Pharmaceuticals | Corvus Pharmaceuticals, Inc.